Rapid Dose Therapeutics Corp.
OTC: RDTCF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mark Andrew Upsdell
- Employees
- 12
- Headquarters
- Burlington, Canada
- IPO year
- 2019
- Market cap
- $1.8M
- Website
- https://www.rapid-dose.com
Loading RDTCF…
Loading profile data…Frequently asked questions about RDTCF
What does Rapid Dose Therapeutics Corp. (RDTCF) do?
Rapid Dose Therapeutics Corp., a life sciences enterprise based in Burlington, Canada, specializes in cutting-edge drug delivery systems aimed at enhancing health and well-being for individuals across Canada. Their core offering is the QuickStrip/PharmaStrip, an innovative oral, fast-dissolving film designed to swiftly introduce active compounds...
Where does RDTCF trade?
Rapid Dose Therapeutics Corp. (RDTCF) trades on the Other OTC.
What sector is RDTCF in?
Rapid Dose Therapeutics Corp. (RDTCF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Rapid Dose Therapeutics Corp.?
Mark Andrew Upsdell is the chief executive officer of Rapid Dose Therapeutics Corp. (RDTCF).
Where is Rapid Dose Therapeutics Corp. headquartered?
Rapid Dose Therapeutics Corp. is headquartered in Canada.
Does RDTCF pay a dividend?
Rapid Dose Therapeutics Corp. (RDTCF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RDTCF go public?
Rapid Dose Therapeutics Corp. (RDTCF) completed its initial public offering in 2019.